The global ketoanalogue for kidney disease market size was exhibited at USD 234.63 million in 2022 and is projected to hit around USD 448.78 million by 2032, growing at a CAGR of 6.7% during the forecast period 2023 to 2032. Key Pointers: In te...
The global Gout Therapeutics market size was estimated at USD 2.9 billion in 2021 and is expected to surpass around USD 4.15 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 8.8% during ...
The global Chronic Kidney Disease [CKD] Nutritional Supplement market size was estimated at USD 3.8 billion in 2021 and is expected to surpass around USD 5.20 billion by 2030 and poised to grow at a compound annual growt...
The global Smart Insulin Pens market size was estimated at USD 100.2 billion in 2021 and is expected to surpass around USD 209.4 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 15.2% du...
The global Equine Supplement Products market size was estimated at USD 91.4 million in 2021 and is expected to surpass around USD 150 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.7...
The global epilepsy therapeutics market size was exhibited at USD 12.34 billion in 2022 and is projected to hit around USD 17.75 billion by 2032, growing at a CAGR of 3.7% during the forecast period 2023 to 2032. Epilepsy is a chronic neurological...
The global Pseudomonas Aeruginosa Infection Treatment market size was estimated at USD 1.7 billion in 2021 and is expected to surpass around USD 2.9 billion by 2030 and poised to grow at a compound annual growth rate&nbs...
The global Joint Pain Injections market size was estimated at USD 4.15 billion in 2021 and is expected to surpass around USD 9.10 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 7.9% du...
The global Water for Injection market size was estimated at USD 21.8 billion in 2021 and is expected to surpass around USD 53.15 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 9.1...
The global venous diseases treatment market size was estimated at USD 10.24 billion in 2022 and is expected to surpass around USD 19.59 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2023...